Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells

Journal of Neural Transmission, Supplement

Volumn , Issue 55, 1999, Pages 47-55

  Scarselli, M ^b   Barbier, P ^b   Salvadori, F ^b   Armogida, M ^b   Collecchi, P ^b   Pardini, C ^b   Vaglini, F ^b   Maggio, R ^b   Corsini, Giovanni U ^a  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DNA; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LACTATE DEHYDROGENASE; SPIPERONE; THYMIDINE; TRITIUM; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL PROLIFERATION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CYCLE; CELL DIVISION; DRUG EFFECT; HAMSTER;

ANIMALS; APOMORPHINE; CELL CYCLE; CELL DIVISION; CHO CELLS; CRICETINAE;

EID: 0032589183     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6369-6_5     Document Type: Article

References (21)

1. Anden NE, Rubenson A, Fuxe K, Hokfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmac 19: 627-629
2. Ben-Shachar D, Riederer P, Youdim MBH (1991) Iron-melanin interaction and lipid peroxidation: implication for Parkinson's disease. J Neurochem 57: 1609-1614
3. Ernst AM (1967) Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 10: 316-323
4. Ferriola PC, Cody V, Middleton EJr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38: 1617-1624
5. Gassen M, Glinka Y, Pinchasi B, Youdim MBH (1996) Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction. Eur J Pharmacol 308: 219-225
6. 2 and 6-hydroxydopamine. Mov Disord 13: 242-248
7. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14: 633-643
8. 3H]dopamine: impact of ascorbic acid and glutathione. J Neurochem 63: 1126-1132
9. Iversen LL, Rogawski MA, Miller RJ (1976) Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanism in the rat striatum. Mol Pharmacol 12: 251-262
10. Kang TB, Liang NC (1997) Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54: 1013-1018
11. Lal S (1988) Apomorphine in the evaluation of dopaminergic function in man. Prog Neuropsychopharmacol Biol Psychiatry 12: 117-164
12. Lees AJ (1993) Dopamine agonists in Parkinson's disease: a look at apomorphine. Fundam Clin Pharmacol 7: 121-128
13. Liu J, Mori A (1993) Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch Biochem Biophys 302: 118-127
14. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1329-1331
15. Neumeyer JL, Neustadt BR, Weinhardt KK (1970) Aporphines. V. Total synthesis of (plus or minus)-apomorphine. J Pharm Sci 59: 1850-1852
16. Nishizuka Y (1989) Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 63: 1892-1903
17. Rosenberg PA (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci 8: 2887-2894
18. Saari WS, King KK, Lotti KK (1973) Synthesis and biological activity of (6aS)-10,11-dihydroxyaporphine, the optical antipode of apomorphine. J Med Chem 16: 171-172
19. Shen RS, Smith KK, Davis PJ, Ahell CW (1984) Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogues. J Biol Chem 259: 8994-9000
20. Sheppard H, Wiggan G (1971) Different sensitivities of the phosphodiesterases (adenosinc-3′,5′-cyclic phosphate 3′-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold. Biochem Pharmacol 20: 2128-2130
21. Wang BH, Lu ZX, Polya GM (1997) Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids. Planta Mcd 63(6): 494-498